265 related articles for article (PubMed ID: 24211260)
1. Perfusion and vascular permeability: basic concepts and measurement in DCE-CT and DCE-MRI.
Cuenod CA; Balvay D
Diagn Interv Imaging; 2013 Dec; 94(12):1187-204. PubMed ID: 24211260
[TBL] [Abstract][Full Text] [Related]
2. Dynamic contrast-enhanced MRI in oncology: how we do it.
Petralia G; Summers PE; Agostini A; Ambrosini R; Cianci R; Cristel G; Calistri L; Colagrande S
Radiol Med; 2020 Dec; 125(12):1288-1300. PubMed ID: 32415476
[TBL] [Abstract][Full Text] [Related]
3. Reproducibility of the aortic input function (AIF) derived from dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) of the kidneys in a volunteer study.
Mendichovszky IA; Cutajar M; Gordon I
Eur J Radiol; 2009 Sep; 71(3):576-81. PubMed ID: 19004588
[TBL] [Abstract][Full Text] [Related]
4. Imaging vascular and hemodynamic features of the brain using dynamic susceptibility contrast and dynamic contrast enhanced MRI.
Quarles CC; Bell LC; Stokes AM
Neuroimage; 2019 Feb; 187():32-55. PubMed ID: 29729392
[TBL] [Abstract][Full Text] [Related]
5. [Perfusion by magnetic resonance imaging: its physical foundations and clinical application].
Fayed-Miguel N; Castillo-Blandino J; Medrano-Lin J
Rev Neurol; 2010 Jan 1-15; 50(1):23-32. PubMed ID: 20073020
[TBL] [Abstract][Full Text] [Related]
6. Quantitative perfusion analysis of malignant liver tumors: dynamic computed tomography and contrast-enhanced ultrasound.
Goetti R; Reiner CS; Knuth A; Klotz E; Stenner F; Samaras P; Alkadhi H
Invest Radiol; 2012 Jan; 47(1):18-24. PubMed ID: 21788906
[TBL] [Abstract][Full Text] [Related]
7. Absolute quantification of regional renal blood flow in swine by dynamic contrast-enhanced magnetic resonance imaging using a blood pool contrast agent.
Lüdemann L; Nafz B; Elsner F; Grosse-Siestrup C; Meissler M; Kaufels N; Rehbein H; Persson PB; Michaely HJ; Lengsfeld P; Voth M; Gutberlet M
Invest Radiol; 2009 Mar; 44(3):125-34. PubMed ID: 19151609
[TBL] [Abstract][Full Text] [Related]
8. [Myocardial microcirculation in humans--new approaches using MRI].
Wacker CM; Bauer WR
Herz; 2003 Mar; 28(2):74-81. PubMed ID: 12669220
[TBL] [Abstract][Full Text] [Related]
9. Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications.
Jain R
NMR Biomed; 2013 Aug; 26(8):1042-9. PubMed ID: 23832526
[TBL] [Abstract][Full Text] [Related]
10. A review of technical aspects of T1-weighted dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) in human brain tumors.
Bergamino M; Bonzano L; Levrero F; Mancardi GL; Roccatagliata L
Phys Med; 2014 Sep; 30(6):635-43. PubMed ID: 24793824
[TBL] [Abstract][Full Text] [Related]
11. Technical aspects of MR perfusion.
Sourbron S
Eur J Radiol; 2010 Dec; 76(3):304-13. PubMed ID: 20363574
[TBL] [Abstract][Full Text] [Related]
12. Tracer-kinetic modeling of dynamic contrast-enhanced MRI and CT: a primer.
Ingrisch M; Sourbron S
J Pharmacokinet Pharmacodyn; 2013 Jun; 40(3):281-300. PubMed ID: 23563847
[TBL] [Abstract][Full Text] [Related]
13. Dynamic contrast-enhanced MRI and CT provide comparable measurement of blood-brain barrier permeability in a rodent stroke model.
Merali Z; Wong T; Leung J; Gao MM; Mikulis D; Kassner A
Magn Reson Imaging; 2015 Oct; 33(8):1007-12. PubMed ID: 26117703
[TBL] [Abstract][Full Text] [Related]
14. Correlative assessment of tumor microcirculation using contrast-enhanced perfusion MRI and intravoxel incoherent motion diffusion-weighted MRI: is there a link between them?
Bisdas S; Braun C; Skardelly M; Schittenhelm J; Teo TH; Thng CH; Klose U; Koh TS
NMR Biomed; 2014 Oct; 27(10):1184-91. PubMed ID: 25088433
[TBL] [Abstract][Full Text] [Related]
15. A method for pharmacokinetic modelling of dynamic contrast enhanced MRI studies of rapidly enhancing lesions acquired in a clinical setting.
Radjenovic A; Ridgway JP; Smith MA
Phys Med Biol; 2006 May; 51(9):N187-97. PubMed ID: 16625029
[TBL] [Abstract][Full Text] [Related]
16. Spiral Perfusion Imaging With Consecutive Echoes (SPICE™) for the Simultaneous Mapping of DSC- and DCE-MRI Parameters in Brain Tumor Patients: Theory and Initial Feasibility.
Paulson ES; Prah DE; Schmainda KM
Tomography; 2016 Dec; 2(4):295-307. PubMed ID: 28090589
[TBL] [Abstract][Full Text] [Related]
17. Dynamic contrast-enhanced magnetic resonance imaging: applications in oncology.
Teo QQ; Thng CH; Koh TS; Ng QS
Clin Oncol (R Coll Radiol); 2014 Oct; 26(10):e9-20. PubMed ID: 24931594
[TBL] [Abstract][Full Text] [Related]
18. Brain tumor perfusion: comparison of dynamic contrast enhanced magnetic resonance imaging using T1, T2, and T2* contrast, pulsed arterial spin labeling, and H2(15)O positron emission tomography.
Lüdemann L; Warmuth C; Plotkin M; Förschler A; Gutberlet M; Wust P; Amthauer H
Eur J Radiol; 2009 Jun; 70(3):465-74. PubMed ID: 18359598
[TBL] [Abstract][Full Text] [Related]
19. Dynamic contrast-enhanced micro-computed tomography correlates with 3-dimensional fluorescence ultramicroscopy in antiangiogenic therapy of breast cancer xenografts.
Pöschinger T; Renner A; Eisa F; Dobosz M; Strobel S; Weber TG; Brauweiler R; Kalender WA; Scheuer W
Invest Radiol; 2014 Jul; 49(7):445-56. PubMed ID: 24598441
[TBL] [Abstract][Full Text] [Related]
20. Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements.
Brix G; Griebel J; Kiessling F; Wenz F
Eur J Nucl Med Mol Imaging; 2010 Aug; 37 Suppl 1():S30-51. PubMed ID: 20503049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
